Evidence map›Paper›PMID 28103630›Full record

ArticleCellular microbiology2017

Orientia tsutsugamushi Ank9 is a multifunctional effector that utilizes a novel GRIP-like Golgi localization domain for Golgi-to-endoplasmic reticulum trafficking and interacts with host COPB2.

Andrea R Beyer, Kyle G Rodino, Lauren VieBrock, Ryan S Green, Brittney K Tegels, Lee D Oliver, Richard T Marconi, Jason A Carlyon

Open access · bronzeAbstract read
In one paragraph

Article in Cellular microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Transformation and allelic exchange inbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Pathogens (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Pathogens (Basel, Switzerland) · 2025
    Article
  10. Infection and immunity · 2025
    Article
  11. Infection and immunity · 2024
    Article
  12. Article
  13. mSphere · 2023
    Article
  14. bioRxiv : the preprint server for biology · 2023
    Article
  15. Type 1 secretion system and effectors in Rickettsiales.Frontiers in cellular and infection microbiology · 2023
    Review
  16. Article
  17. Pathogens (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Article
  20. Moonlighting in Rickettsiales: Expanding Virulence Landscape.Tropical medicine and infectious disease · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrea R BeyerDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Kyle G RodinoDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Lauren VieBrockDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Ryan S GreenDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Brittney K TegelsDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Lee D OliverDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Richard T MarconiDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Jason A CarlyonDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.ORCID 0000-0003-2778-5066
Virginia Commonwealth University · USTektronix (United States) · USVirginia State University · US

Funding

Virginia Commonwealth University IRADCAK12GM093857 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI DANIEL C BULLARD, John J Ryan · 2010 to 2026
$7.0M
Defining the pathobiological roles of Orientia tsutsugamushi Ank proteinsR01AI123346 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2017 to 2020
$1.5M
Defining the pathobiological roles of Orientia tsutsugamushi Ank proteinsR56AI123346 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2016 to 2021
$833k
Orientia tsutsugamushi modulation of host cell ubiquitination machineryR21AI103606 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2013 to 2014
$406k
Functional characterization of Orientia tsutsugamushi ankryin repeat proteinsR03AI101666 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2012 to 2013
$150k
NIAID NIH HHS R01 AI123346NIAID NIH HHS R03 AI101666NIAID NIH HHS R21 AI103606NIAID NIH HHS R56 AI123346NIGMS NIH HHS K12 GM093857
6 · The paper itself

Abstract

Orientia tsutsugamushi causes scrub typhus, a potentially fatal infection that afflicts 1 million people annually. This obligate intracellular bacterium boasts one of the largest microbial arsenals of ankyrin repeat-containing protein (Ank) effectors, most of which target the endoplasmic reticulum (ER) by undefined mechanisms. Ank9 is the only one proven to function during infection. Here, we demonstrate that Ank9 bears a motif that mimics the GRIP domain of eukaryotic golgins and is necessary and sufficient for its Golgi localization. Ank9 reaches the ER exclusively by retrograde trafficking from the Golgi. Consistent with this observation, it binds COPB2, a host protein that mediates Golgi-to-ER transport. Ank9 destabilizes the Golgi and ER in a Golgi localization domain-dependent manner and induces the activating transcription factor 4-dependent unfolded protein response. The Golgi is also destabilized in cells infected with O. tsutsugamushi or treated with COPB2 small interfering RNA. COPB2 reduction and/or the cellular events that it invokes, such as Golgi destabilization, benefit Orientia replication. Thus, Ank9 or bacterial negative modulation of COPB2 might contribute to the bacterium's intracellular replication. This report identifies a novel microbial Golgi localization domain, links Ank9 to the ability of O. tsutsugamushi to perturb Golgi structure, and describes the first mechanism by which any Orientia effector targets the secretory pathway.

Indexed as

Activating Transcription Factor 4AnkyrinsBacterial ProteinsCell Line, TumorCoatomer ProteinEndoplasmic ReticulumGolgi ApparatusHeLa CellsHumansOrientia tsutsugamushiProtein BindingProtein DomainsProtein TransportRNA InterferenceRNA, Small InterferingScrub TyphusActivating Transcription Factor 4AnkyrinsATF4 protein, humanBacterial ProteinsCoatomer ProteinCOPB2 protein, humanRNA, Small Interferingankyrin repeat-containing proteinsbacterial effectorsGolgi localization domainintracellular bacteriaretrograde traffickingRickettsia

Identifiers

PMID28103630
PMCPMC5469707
OpenAlexW2582443040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.